Last Updated: June 30, 2026

Suppliers and packagers for blujepa

✉ Email this page to a colleague

« Back to Dashboard

blujepa

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Glaxosmithkline	BLUJEPA	gepotidacin mesylate	TABLET;ORAL	218230	NDA	GlaxoSmithKline LLC	0173-0922-38	8 TABLET, FILM COATED in 1 BOTTLE (0173-0922-38)	2025-03-25
Glaxosmithkline	BLUJEPA	gepotidacin mesylate	TABLET;ORAL	218230	NDA	GlaxoSmithKline LLC	0173-0922-45	20 TABLET, FILM COATED in 1 BOTTLE (0173-0922-45)	2025-03-25
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Suppliers and packagers for blujepa

Last updated: June 1, 2026

BLUJEPA suppliers: who manufactures Blu-Jepp? (BLUJEPA drug substance and product supply chain)

What is BLUJEPA’s contract manufacturing and drug supply chain?

No complete, reliable supplier dataset is available from the information provided.

Which companies supply BLUJEPA’s active pharmaceutical ingredient (API) and intermediates?

No complete, reliable supplier dataset is available from the information provided.

What finished-dose manufacturers (CDMOs) supply BLUJEPA for U.S. distribution?

No complete, reliable supplier dataset is available from the information provided.

What contract manufacturing sites and fill-finish partners produce BLUJEPA drug product?

No complete, reliable supplier dataset is available from the information provided.

What does the Orange Book list for BLUJEPA that can identify suppliers?

No complete, reliable supplier dataset is available from the information provided.

How does BLUJEPA’s supply chain compare with other products in the same therapeutic class?

No complete, reliable supplier dataset is available from the information provided.

When do BLUJEPA supply contracts change, and how does that affect continuity of supply?

No complete, reliable supplier dataset is available from the information provided.

What generic or biosimilar development risks exist for BLUJEPA that could affect supply?

No complete, reliable supplier dataset is available from the information provided.

Which suppliers are implicated in BLUJEPA manufacturing after FDA actions (warning letters, recalls, OAI citations)?

No complete, reliable supplier dataset is available from the information provided.

Key Takeaways

A complete supplier map for BLUJEPA (API, finished-dose manufacturing, fill-finish, and labeled site partners) cannot be produced from the provided input.

FAQs

How do I identify BLUJEPA’s API supplier from regulatory filings?
Which BLUJEPA manufacturing sites are typically listed on U.S. labels and packaging?
How can I map BLUJEPA contract manufacturers using establishment registrations (CDER/CARD)?
Do BLUJEPA supply arrangements change during commercial scale-up or post-approval?
What evidence sources best pinpoint BLUJEPA suppliers in IP and litigation records?

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.